Skip to main content

Polar Capital Holdings Plc

Source: SEC Form 13F · as of Mar 2026

Polar Capital Holdings Plc holds 30 biotech & pharma companies tracked by BioSniper, totaling $2.41B in value as of Mar 2026 (SEC Form 13F).

Companies held

30

Total value held

$2.41B

BioSniper AIPage evidence connected

Prepared research question

What matters most for Enliven Therapeutics, Inc. (ELVN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ELVNEnliven Therapeutics, Inc.5,065,933$198.6M
NUVLNuvalent, Inc.1,831,253$187.6M
BBIOBridgeBio Pharma, Inc.2,519,306$187.1M
TEVATeva Pharmaceutical Industries Limited5,175,058$155.9M
REGNREGENERON PHARMACEUTICALS, INC.192,546$148.8M
RYTMRHYTHM PHARMACEUTICALS, INC.1,615,586$140.5M
ARQTArcutis Biotherapeutics, Inc.5,666,940$133.5M
RVMDREVOLUTION MEDICINES, INC.1,133,930$110.3M
CYTKCYTOKINETICS INC1,661,248$109.5M
SRRKScholar Rock Holding Corp1,983,628$97.5M
NAMSNEWAMSTERDAM PHARMA CO N.V.2,831,607$90.6M
DNTHDianthus Therapeutics, Inc. /DE/1,076,009$90.3M
ALNYALNYLAM PHARMACEUTICALS, INC.257,674$85.3M
PCVXVaxcyte, Inc.1,425,788$82.9M
IONSIONIS PHARMACEUTICALS INC829,511$62.3M
INSMINSMED Inc368,107$60.2M
SLNOSOLENO THERAPEUTICS INC1,698,855$56.9M
SVRASavara Inc9,541,786$52.1M
ORKAOruka Therapeutics, Inc.1,047,693$51.4M
ZBIOZenas BioPharma, Inc.2,548,444$49.8M
APGEApogee Therapeutics, Inc.539,177$45.4M
ROIVRoivant Sciences Ltd.1,578,308$43.7M
SYRESpyre Therapeutics, Inc.792,847$40.0M
STOKStoke Therapeutics, Inc.1,132,511$36.9M
OLMAOlema Pharmaceuticals, Inc.1,602,970$23.9M
PHVSPharvaris N.V.781,016$22.1M
BIOABioAge Labs, Inc.1,132,640$19.8M
IVAInventiva S.A.2,132,138$11.8M
RLMDRELMADA THERAPEUTICS, INC.1,414,621$9.8M
ORICOric Pharmaceuticals, Inc.539,377$6.8M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.